Literature DB >> 19543862

Is humeral segmental defect replacement device a stronger construct than locked IM nailing?

Robert Heck1, Ruxandra Marinescu, Haden Janda, Seth Cooper, Jason Schroeder.   

Abstract

Intramedullary (IM) nailing is currently the most common method for treating patients with impending pathologic humeral fractures; however, this treatment is associated with known complications primarily owing to violation of the rotator cuff during insertion. A better option is needed. To determine if a humeral segmental replacement prosthesis would provide a stronger construct compared with an IM nail in this setting, we compared the mechanical properties of these two devices in a cadaver model simulating an impending pathologic fracture. In each of nine matched pairs of fresh human humeri one was randomly selected to undergo a 50% lateral middiaphyseal defect simulating an impending pathologic fracture and subsequent fixation with an IM nail and bone cement. The contralateral humerus underwent fixation using a humeral segmental defect prosthesis. We determined T-scores using DEXA. Each specimen subsequently was tested in torsion to failure. Peak torque and peak rotation at failure were greater for the prosthesis specimens whereas torsional stiffness was greater for the IM nail specimens. We found a linear relationship between peak torque and T-score for each device with the slopes of the lines suggesting the construct with the prosthesis can withstand greater forces than the IM nail and the differences between devices were greater in weaker bones.

Entities:  

Mesh:

Year:  2009        PMID: 19543862      PMCID: PMC2795839          DOI: 10.1007/s11999-009-0947-y

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  21 in total

1.  Does the second-generation intercalary humeral spacer improve on the first?

Authors:  Timothy A Damron; Taninnit Leerapun; Ronald R Hugate; Thomas C Shives; Franklin H Sim
Journal:  Clin Orthop Relat Res       Date:  2008-04-18       Impact factor: 4.176

Review 2.  Treatment of metastatic adenocarcinoma of the pelvis and the extremities.

Authors:  A D Aaron
Journal:  J Bone Joint Surg Am       Date:  1997-06       Impact factor: 5.284

3.  Treatment of pathologic fractures of the humerus with Seidel nailing.

Authors:  J Tomé; B Carsi; C García-Fernández; F Marco; L López-Durán Stern
Journal:  Clin Orthop Relat Res       Date:  1998-05       Impact factor: 4.176

4.  Randomized prospective study of humeral shaft fracture fixation: intramedullary nails versus plates.

Authors:  J R Chapman; M B Henley; J Agel; P J Benca
Journal:  J Orthop Trauma       Date:  2000 Mar-Apr       Impact factor: 2.512

Review 5.  Complications of intramedullary nailing for fractures of the humeral shaft: a review.

Authors:  A F Farragos; E H Schemitsch; M D McKee
Journal:  J Orthop Trauma       Date:  1999-05       Impact factor: 2.512

Review 6.  Management of metastatic lesions of the humerus.

Authors:  C J Bashore; H T Temple
Journal:  Orthop Clin North Am       Date:  2000-10       Impact factor: 2.472

7.  Biomechanical analysis of prophylactic fixation for middle third humeral impending pathologic fractures.

Authors:  T A Damron; M G Rock; S N Choudhury; J J Grabowski; K N An
Journal:  Clin Orthop Relat Res       Date:  1999-06       Impact factor: 4.176

8.  Interlocking intramedullary nailing of pathological fractures of the shaft of the humerus.

Authors:  B J Redmond; J S Biermann; R B Blasier
Journal:  J Bone Joint Surg Am       Date:  1996-06       Impact factor: 5.284

9.  Intercalary spacers in the treatment of segmentally destructive diaphyseal humeral lesions in disseminated malignancies.

Authors:  T A Damron; F H Sim; T C Shives; K N An; M G Rock; D J Pritchard
Journal:  Clin Orthop Relat Res       Date:  1996-03       Impact factor: 4.176

10.  The role of prophylactic surgery in the management of metastatic hip disease.

Authors:  S Gitelis; M B Sheinkop; K Hammerberg; P Brugliera
Journal:  Orthopedics       Date:  1982-08       Impact factor: 1.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.